Global Radioimmunotherapy Market Research Report 2024(Status and Outlook)
Report Overview:
Radioimmunotherapy (RIT) is a type of targeted cancer therapy that combines the specificity of monoclonal antibodies with the destructive power of radiation. The treatment involves attaching radioactive isotopes to monoclonal antibodies, which are specialized proteins that can recognize and bind to specific antigens found on the surface of cancer cells.
The Global Radioimmunotherapy Market Size was estimated at USD 1713.83 million in 2023 and is projected to reach USD 4487.20 million by 2029, exhibiting a CAGR of 17.40% during the forecast period.
This report provides a deep insight into the global Radioimmunotherapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Radioimmunotherapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Radioimmunotherapy market in any manner.
Global Radioimmunotherapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Bayer
Novartis
Lantheus
Aurobindo Pharma
Mundipharma
China Isotope & Radiation
Curium Pharmaceuticals
Gilead Sciences
Clarity Pharmaceuticals
Curasight
Nordic Nanovector
Philogen
RadioMedix
Telix Pharmaceuticals
Orano Med
Actinium Pharmaceuticals
Y-mAbs Therapeutics
Fusion Pharmaceuticals
Market Segmentation (by Type)
Beta-emitting
Targeted Alpha Therapy
Market Segmentation (by Application)
Solid Tumor
Non Hodgkin Lymphoma
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Radioimmunotherapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Radioimmunotherapy (RIT) is a type of targeted cancer therapy that combines the specificity of monoclonal antibodies with the destructive power of radiation. The treatment involves attaching radioactive isotopes to monoclonal antibodies, which are specialized proteins that can recognize and bind to specific antigens found on the surface of cancer cells.
The Global Radioimmunotherapy Market Size was estimated at USD 1713.83 million in 2023 and is projected to reach USD 4487.20 million by 2029, exhibiting a CAGR of 17.40% during the forecast period.
This report provides a deep insight into the global Radioimmunotherapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Radioimmunotherapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Radioimmunotherapy market in any manner.
Global Radioimmunotherapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Bayer
Novartis
Lantheus
Aurobindo Pharma
Mundipharma
China Isotope & Radiation
Curium Pharmaceuticals
Gilead Sciences
Clarity Pharmaceuticals
Curasight
Nordic Nanovector
Philogen
RadioMedix
Telix Pharmaceuticals
Orano Med
Actinium Pharmaceuticals
Y-mAbs Therapeutics
Fusion Pharmaceuticals
Market Segmentation (by Type)
Beta-emitting
Targeted Alpha Therapy
Market Segmentation (by Application)
Solid Tumor
Non Hodgkin Lymphoma
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Radioimmunotherapy Market
- Overview of the regional outlook of the Radioimmunotherapy Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Radioimmunotherapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Radioimmunotherapy
1.2 Key Market Segments
1.2.1 Radioimmunotherapy Segment by Type
1.2.2 Radioimmunotherapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RADIOIMMUNOTHERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Radioimmunotherapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Radioimmunotherapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RADIOIMMUNOTHERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Global Radioimmunotherapy Sales by Manufacturers (2019-2024)
3.2 Global Radioimmunotherapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Radioimmunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Radioimmunotherapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Radioimmunotherapy Sales Sites, Area Served, Product Type
3.6 Radioimmunotherapy Market Competitive Situation and Trends
3.6.1 Radioimmunotherapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Radioimmunotherapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 RADIOIMMUNOTHERAPY INDUSTRY CHAIN ANALYSIS
4.1 Radioimmunotherapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RADIOIMMUNOTHERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 RADIOIMMUNOTHERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Radioimmunotherapy Sales Market Share by Type (2019-2024)
6.3 Global Radioimmunotherapy Market Size Market Share by Type (2019-2024)
6.4 Global Radioimmunotherapy Price by Type (2019-2024)
7 RADIOIMMUNOTHERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Radioimmunotherapy Market Sales by Application (2019-2024)
7.3 Global Radioimmunotherapy Market Size (M USD) by Application (2019-2024)
7.4 Global Radioimmunotherapy Sales Growth Rate by Application (2019-2024)
8 RADIOIMMUNOTHERAPY MARKET SEGMENTATION BY REGION
8.1 Global Radioimmunotherapy Sales by Region
8.1.1 Global Radioimmunotherapy Sales by Region
8.1.2 Global Radioimmunotherapy Sales Market Share by Region
8.2 North America
8.2.1 North America Radioimmunotherapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Radioimmunotherapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Radioimmunotherapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Radioimmunotherapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Radioimmunotherapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Bayer
9.1.1 Bayer Radioimmunotherapy Basic Information
9.1.2 Bayer Radioimmunotherapy Product Overview
9.1.3 Bayer Radioimmunotherapy Product Market Performance
9.1.4 Bayer Business Overview
9.1.5 Bayer Radioimmunotherapy SWOT Analysis
9.1.6 Bayer Recent Developments
9.2 Novartis
9.2.1 Novartis Radioimmunotherapy Basic Information
9.2.2 Novartis Radioimmunotherapy Product Overview
9.2.3 Novartis Radioimmunotherapy Product Market Performance
9.2.4 Novartis Business Overview
9.2.5 Novartis Radioimmunotherapy SWOT Analysis
9.2.6 Novartis Recent Developments
9.3 Lantheus
9.3.1 Lantheus Radioimmunotherapy Basic Information
9.3.2 Lantheus Radioimmunotherapy Product Overview
9.3.3 Lantheus Radioimmunotherapy Product Market Performance
9.3.4 Lantheus Radioimmunotherapy SWOT Analysis
9.3.5 Lantheus Business Overview
9.3.6 Lantheus Recent Developments
9.4 Aurobindo Pharma
9.4.1 Aurobindo Pharma Radioimmunotherapy Basic Information
9.4.2 Aurobindo Pharma Radioimmunotherapy Product Overview
9.4.3 Aurobindo Pharma Radioimmunotherapy Product Market Performance
9.4.4 Aurobindo Pharma Business Overview
9.4.5 Aurobindo Pharma Recent Developments
9.5 Mundipharma
9.5.1 Mundipharma Radioimmunotherapy Basic Information
9.5.2 Mundipharma Radioimmunotherapy Product Overview
9.5.3 Mundipharma Radioimmunotherapy Product Market Performance
9.5.4 Mundipharma Business Overview
9.5.5 Mundipharma Recent Developments
9.6 China Isotope and Radiation
9.6.1 China Isotope and Radiation Radioimmunotherapy Basic Information
9.6.2 China Isotope and Radiation Radioimmunotherapy Product Overview
9.6.3 China Isotope and Radiation Radioimmunotherapy Product Market Performance
9.6.4 China Isotope and Radiation Business Overview
9.6.5 China Isotope and Radiation Recent Developments
9.7 Curium Pharmaceuticals
9.7.1 Curium Pharmaceuticals Radioimmunotherapy Basic Information
9.7.2 Curium Pharmaceuticals Radioimmunotherapy Product Overview
9.7.3 Curium Pharmaceuticals Radioimmunotherapy Product Market Performance
9.7.4 Curium Pharmaceuticals Business Overview
9.7.5 Curium Pharmaceuticals Recent Developments
9.8 Gilead Sciences
9.8.1 Gilead Sciences Radioimmunotherapy Basic Information
9.8.2 Gilead Sciences Radioimmunotherapy Product Overview
9.8.3 Gilead Sciences Radioimmunotherapy Product Market Performance
9.8.4 Gilead Sciences Business Overview
9.8.5 Gilead Sciences Recent Developments
9.9 Clarity Pharmaceuticals
9.9.1 Clarity Pharmaceuticals Radioimmunotherapy Basic Information
9.9.2 Clarity Pharmaceuticals Radioimmunotherapy Product Overview
9.9.3 Clarity Pharmaceuticals Radioimmunotherapy Product Market Performance
9.9.4 Clarity Pharmaceuticals Business Overview
9.9.5 Clarity Pharmaceuticals Recent Developments
9.10 Curasight
9.10.1 Curasight Radioimmunotherapy Basic Information
9.10.2 Curasight Radioimmunotherapy Product Overview
9.10.3 Curasight Radioimmunotherapy Product Market Performance
9.10.4 Curasight Business Overview
9.10.5 Curasight Recent Developments
9.11 Nordic Nanovector
9.11.1 Nordic Nanovector Radioimmunotherapy Basic Information
9.11.2 Nordic Nanovector Radioimmunotherapy Product Overview
9.11.3 Nordic Nanovector Radioimmunotherapy Product Market Performance
9.11.4 Nordic Nanovector Business Overview
9.11.5 Nordic Nanovector Recent Developments
9.12 Philogen
9.12.1 Philogen Radioimmunotherapy Basic Information
9.12.2 Philogen Radioimmunotherapy Product Overview
9.12.3 Philogen Radioimmunotherapy Product Market Performance
9.12.4 Philogen Business Overview
9.12.5 Philogen Recent Developments
9.13 RadioMedix
9.13.1 RadioMedix Radioimmunotherapy Basic Information
9.13.2 RadioMedix Radioimmunotherapy Product Overview
9.13.3 RadioMedix Radioimmunotherapy Product Market Performance
9.13.4 RadioMedix Business Overview
9.13.5 RadioMedix Recent Developments
9.14 Telix Pharmaceuticals
9.14.1 Telix Pharmaceuticals Radioimmunotherapy Basic Information
9.14.2 Telix Pharmaceuticals Radioimmunotherapy Product Overview
9.14.3 Telix Pharmaceuticals Radioimmunotherapy Product Market Performance
9.14.4 Telix Pharmaceuticals Business Overview
9.14.5 Telix Pharmaceuticals Recent Developments
9.15 Orano Med
9.15.1 Orano Med Radioimmunotherapy Basic Information
9.15.2 Orano Med Radioimmunotherapy Product Overview
9.15.3 Orano Med Radioimmunotherapy Product Market Performance
9.15.4 Orano Med Business Overview
9.15.5 Orano Med Recent Developments
9.16 Actinium Pharmaceuticals
9.16.1 Actinium Pharmaceuticals Radioimmunotherapy Basic Information
9.16.2 Actinium Pharmaceuticals Radioimmunotherapy Product Overview
9.16.3 Actinium Pharmaceuticals Radioimmunotherapy Product Market Performance
9.16.4 Actinium Pharmaceuticals Business Overview
9.16.5 Actinium Pharmaceuticals Recent Developments
9.17 Y-mAbs Therapeutics
9.17.1 Y-mAbs Therapeutics Radioimmunotherapy Basic Information
9.17.2 Y-mAbs Therapeutics Radioimmunotherapy Product Overview
9.17.3 Y-mAbs Therapeutics Radioimmunotherapy Product Market Performance
9.17.4 Y-mAbs Therapeutics Business Overview
9.17.5 Y-mAbs Therapeutics Recent Developments
9.18 Fusion Pharmaceuticals
9.18.1 Fusion Pharmaceuticals Radioimmunotherapy Basic Information
9.18.2 Fusion Pharmaceuticals Radioimmunotherapy Product Overview
9.18.3 Fusion Pharmaceuticals Radioimmunotherapy Product Market Performance
9.18.4 Fusion Pharmaceuticals Business Overview
9.18.5 Fusion Pharmaceuticals Recent Developments
10 RADIOIMMUNOTHERAPY MARKET FORECAST BY REGION
10.1 Global Radioimmunotherapy Market Size Forecast
10.2 Global Radioimmunotherapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Radioimmunotherapy Market Size Forecast by Country
10.2.3 Asia Pacific Radioimmunotherapy Market Size Forecast by Region
10.2.4 South America Radioimmunotherapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Radioimmunotherapy by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Radioimmunotherapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Radioimmunotherapy by Type (2025-2030)
11.1.2 Global Radioimmunotherapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Radioimmunotherapy by Type (2025-2030)
11.2 Global Radioimmunotherapy Market Forecast by Application (2025-2030)
11.2.1 Global Radioimmunotherapy Sales (Kilotons) Forecast by Application
11.2.2 Global Radioimmunotherapy Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Radioimmunotherapy
1.2 Key Market Segments
1.2.1 Radioimmunotherapy Segment by Type
1.2.2 Radioimmunotherapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RADIOIMMUNOTHERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Radioimmunotherapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Radioimmunotherapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RADIOIMMUNOTHERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Global Radioimmunotherapy Sales by Manufacturers (2019-2024)
3.2 Global Radioimmunotherapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Radioimmunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Radioimmunotherapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Radioimmunotherapy Sales Sites, Area Served, Product Type
3.6 Radioimmunotherapy Market Competitive Situation and Trends
3.6.1 Radioimmunotherapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Radioimmunotherapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 RADIOIMMUNOTHERAPY INDUSTRY CHAIN ANALYSIS
4.1 Radioimmunotherapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RADIOIMMUNOTHERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 RADIOIMMUNOTHERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Radioimmunotherapy Sales Market Share by Type (2019-2024)
6.3 Global Radioimmunotherapy Market Size Market Share by Type (2019-2024)
6.4 Global Radioimmunotherapy Price by Type (2019-2024)
7 RADIOIMMUNOTHERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Radioimmunotherapy Market Sales by Application (2019-2024)
7.3 Global Radioimmunotherapy Market Size (M USD) by Application (2019-2024)
7.4 Global Radioimmunotherapy Sales Growth Rate by Application (2019-2024)
8 RADIOIMMUNOTHERAPY MARKET SEGMENTATION BY REGION
8.1 Global Radioimmunotherapy Sales by Region
8.1.1 Global Radioimmunotherapy Sales by Region
8.1.2 Global Radioimmunotherapy Sales Market Share by Region
8.2 North America
8.2.1 North America Radioimmunotherapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Radioimmunotherapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Radioimmunotherapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Radioimmunotherapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Radioimmunotherapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Bayer
9.1.1 Bayer Radioimmunotherapy Basic Information
9.1.2 Bayer Radioimmunotherapy Product Overview
9.1.3 Bayer Radioimmunotherapy Product Market Performance
9.1.4 Bayer Business Overview
9.1.5 Bayer Radioimmunotherapy SWOT Analysis
9.1.6 Bayer Recent Developments
9.2 Novartis
9.2.1 Novartis Radioimmunotherapy Basic Information
9.2.2 Novartis Radioimmunotherapy Product Overview
9.2.3 Novartis Radioimmunotherapy Product Market Performance
9.2.4 Novartis Business Overview
9.2.5 Novartis Radioimmunotherapy SWOT Analysis
9.2.6 Novartis Recent Developments
9.3 Lantheus
9.3.1 Lantheus Radioimmunotherapy Basic Information
9.3.2 Lantheus Radioimmunotherapy Product Overview
9.3.3 Lantheus Radioimmunotherapy Product Market Performance
9.3.4 Lantheus Radioimmunotherapy SWOT Analysis
9.3.5 Lantheus Business Overview
9.3.6 Lantheus Recent Developments
9.4 Aurobindo Pharma
9.4.1 Aurobindo Pharma Radioimmunotherapy Basic Information
9.4.2 Aurobindo Pharma Radioimmunotherapy Product Overview
9.4.3 Aurobindo Pharma Radioimmunotherapy Product Market Performance
9.4.4 Aurobindo Pharma Business Overview
9.4.5 Aurobindo Pharma Recent Developments
9.5 Mundipharma
9.5.1 Mundipharma Radioimmunotherapy Basic Information
9.5.2 Mundipharma Radioimmunotherapy Product Overview
9.5.3 Mundipharma Radioimmunotherapy Product Market Performance
9.5.4 Mundipharma Business Overview
9.5.5 Mundipharma Recent Developments
9.6 China Isotope and Radiation
9.6.1 China Isotope and Radiation Radioimmunotherapy Basic Information
9.6.2 China Isotope and Radiation Radioimmunotherapy Product Overview
9.6.3 China Isotope and Radiation Radioimmunotherapy Product Market Performance
9.6.4 China Isotope and Radiation Business Overview
9.6.5 China Isotope and Radiation Recent Developments
9.7 Curium Pharmaceuticals
9.7.1 Curium Pharmaceuticals Radioimmunotherapy Basic Information
9.7.2 Curium Pharmaceuticals Radioimmunotherapy Product Overview
9.7.3 Curium Pharmaceuticals Radioimmunotherapy Product Market Performance
9.7.4 Curium Pharmaceuticals Business Overview
9.7.5 Curium Pharmaceuticals Recent Developments
9.8 Gilead Sciences
9.8.1 Gilead Sciences Radioimmunotherapy Basic Information
9.8.2 Gilead Sciences Radioimmunotherapy Product Overview
9.8.3 Gilead Sciences Radioimmunotherapy Product Market Performance
9.8.4 Gilead Sciences Business Overview
9.8.5 Gilead Sciences Recent Developments
9.9 Clarity Pharmaceuticals
9.9.1 Clarity Pharmaceuticals Radioimmunotherapy Basic Information
9.9.2 Clarity Pharmaceuticals Radioimmunotherapy Product Overview
9.9.3 Clarity Pharmaceuticals Radioimmunotherapy Product Market Performance
9.9.4 Clarity Pharmaceuticals Business Overview
9.9.5 Clarity Pharmaceuticals Recent Developments
9.10 Curasight
9.10.1 Curasight Radioimmunotherapy Basic Information
9.10.2 Curasight Radioimmunotherapy Product Overview
9.10.3 Curasight Radioimmunotherapy Product Market Performance
9.10.4 Curasight Business Overview
9.10.5 Curasight Recent Developments
9.11 Nordic Nanovector
9.11.1 Nordic Nanovector Radioimmunotherapy Basic Information
9.11.2 Nordic Nanovector Radioimmunotherapy Product Overview
9.11.3 Nordic Nanovector Radioimmunotherapy Product Market Performance
9.11.4 Nordic Nanovector Business Overview
9.11.5 Nordic Nanovector Recent Developments
9.12 Philogen
9.12.1 Philogen Radioimmunotherapy Basic Information
9.12.2 Philogen Radioimmunotherapy Product Overview
9.12.3 Philogen Radioimmunotherapy Product Market Performance
9.12.4 Philogen Business Overview
9.12.5 Philogen Recent Developments
9.13 RadioMedix
9.13.1 RadioMedix Radioimmunotherapy Basic Information
9.13.2 RadioMedix Radioimmunotherapy Product Overview
9.13.3 RadioMedix Radioimmunotherapy Product Market Performance
9.13.4 RadioMedix Business Overview
9.13.5 RadioMedix Recent Developments
9.14 Telix Pharmaceuticals
9.14.1 Telix Pharmaceuticals Radioimmunotherapy Basic Information
9.14.2 Telix Pharmaceuticals Radioimmunotherapy Product Overview
9.14.3 Telix Pharmaceuticals Radioimmunotherapy Product Market Performance
9.14.4 Telix Pharmaceuticals Business Overview
9.14.5 Telix Pharmaceuticals Recent Developments
9.15 Orano Med
9.15.1 Orano Med Radioimmunotherapy Basic Information
9.15.2 Orano Med Radioimmunotherapy Product Overview
9.15.3 Orano Med Radioimmunotherapy Product Market Performance
9.15.4 Orano Med Business Overview
9.15.5 Orano Med Recent Developments
9.16 Actinium Pharmaceuticals
9.16.1 Actinium Pharmaceuticals Radioimmunotherapy Basic Information
9.16.2 Actinium Pharmaceuticals Radioimmunotherapy Product Overview
9.16.3 Actinium Pharmaceuticals Radioimmunotherapy Product Market Performance
9.16.4 Actinium Pharmaceuticals Business Overview
9.16.5 Actinium Pharmaceuticals Recent Developments
9.17 Y-mAbs Therapeutics
9.17.1 Y-mAbs Therapeutics Radioimmunotherapy Basic Information
9.17.2 Y-mAbs Therapeutics Radioimmunotherapy Product Overview
9.17.3 Y-mAbs Therapeutics Radioimmunotherapy Product Market Performance
9.17.4 Y-mAbs Therapeutics Business Overview
9.17.5 Y-mAbs Therapeutics Recent Developments
9.18 Fusion Pharmaceuticals
9.18.1 Fusion Pharmaceuticals Radioimmunotherapy Basic Information
9.18.2 Fusion Pharmaceuticals Radioimmunotherapy Product Overview
9.18.3 Fusion Pharmaceuticals Radioimmunotherapy Product Market Performance
9.18.4 Fusion Pharmaceuticals Business Overview
9.18.5 Fusion Pharmaceuticals Recent Developments
10 RADIOIMMUNOTHERAPY MARKET FORECAST BY REGION
10.1 Global Radioimmunotherapy Market Size Forecast
10.2 Global Radioimmunotherapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Radioimmunotherapy Market Size Forecast by Country
10.2.3 Asia Pacific Radioimmunotherapy Market Size Forecast by Region
10.2.4 South America Radioimmunotherapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Radioimmunotherapy by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Radioimmunotherapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Radioimmunotherapy by Type (2025-2030)
11.1.2 Global Radioimmunotherapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Radioimmunotherapy by Type (2025-2030)
11.2 Global Radioimmunotherapy Market Forecast by Application (2025-2030)
11.2.1 Global Radioimmunotherapy Sales (Kilotons) Forecast by Application
11.2.2 Global Radioimmunotherapy Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Radioimmunotherapy Market Size Comparison by Region (M USD)
Table 5. Global Radioimmunotherapy Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Radioimmunotherapy Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Radioimmunotherapy Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Radioimmunotherapy Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radioimmunotherapy as of 2022)
Table 10. Global Market Radioimmunotherapy Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Radioimmunotherapy Sales Sites and Area Served
Table 12. Manufacturers Radioimmunotherapy Product Type
Table 13. Global Radioimmunotherapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Radioimmunotherapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Radioimmunotherapy Market Challenges
Table 22. Global Radioimmunotherapy Sales by Type (Kilotons)
Table 23. Global Radioimmunotherapy Market Size by Type (M USD)
Table 24. Global Radioimmunotherapy Sales (Kilotons) by Type (2019-2024)
Table 25. Global Radioimmunotherapy Sales Market Share by Type (2019-2024)
Table 26. Global Radioimmunotherapy Market Size (M USD) by Type (2019-2024)
Table 27. Global Radioimmunotherapy Market Size Share by Type (2019-2024)
Table 28. Global Radioimmunotherapy Price (USD/Ton) by Type (2019-2024)
Table 29. Global Radioimmunotherapy Sales (Kilotons) by Application
Table 30. Global Radioimmunotherapy Market Size by Application
Table 31. Global Radioimmunotherapy Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Radioimmunotherapy Sales Market Share by Application (2019-2024)
Table 33. Global Radioimmunotherapy Sales by Application (2019-2024) & (M USD)
Table 34. Global Radioimmunotherapy Market Share by Application (2019-2024)
Table 35. Global Radioimmunotherapy Sales Growth Rate by Application (2019-2024)
Table 36. Global Radioimmunotherapy Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Radioimmunotherapy Sales Market Share by Region (2019-2024)
Table 38. North America Radioimmunotherapy Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Radioimmunotherapy Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Radioimmunotherapy Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Radioimmunotherapy Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Radioimmunotherapy Sales by Region (2019-2024) & (Kilotons)
Table 43. Bayer Radioimmunotherapy Basic Information
Table 44. Bayer Radioimmunotherapy Product Overview
Table 45. Bayer Radioimmunotherapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Bayer Business Overview
Table 47. Bayer Radioimmunotherapy SWOT Analysis
Table 48. Bayer Recent Developments
Table 49. Novartis Radioimmunotherapy Basic Information
Table 50. Novartis Radioimmunotherapy Product Overview
Table 51. Novartis Radioimmunotherapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Novartis Business Overview
Table 53. Novartis Radioimmunotherapy SWOT Analysis
Table 54. Novartis Recent Developments
Table 55. Lantheus Radioimmunotherapy Basic Information
Table 56. Lantheus Radioimmunotherapy Product Overview
Table 57. Lantheus Radioimmunotherapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Lantheus Radioimmunotherapy SWOT Analysis
Table 59. Lantheus Business Overview
Table 60. Lantheus Recent Developments
Table 61. Aurobindo Pharma Radioimmunotherapy Basic Information
Table 62. Aurobindo Pharma Radioimmunotherapy Product Overview
Table 63. Aurobindo Pharma Radioimmunotherapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Aurobindo Pharma Business Overview
Table 65. Aurobindo Pharma Recent Developments
Table 66. Mundipharma Radioimmunotherapy Basic Information
Table 67. Mundipharma Radioimmunotherapy Product Overview
Table 68. Mundipharma Radioimmunotherapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Mundipharma Business Overview
Table 70. Mundipharma Recent Developments
Table 71. China Isotope and Radiation Radioimmunotherapy Basic Information
Table 72. China Isotope and Radiation Radioimmunotherapy Product Overview
Table 73. China Isotope and Radiation Radioimmunotherapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. China Isotope and Radiation Business Overview
Table 75. China Isotope and Radiation Recent Developments
Table 76. Curium Pharmaceuticals Radioimmunotherapy Basic Information
Table 77. Curium Pharmaceuticals Radioimmunotherapy Product Overview
Table 78. Curium Pharmaceuticals Radioimmunotherapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Curium Pharmaceuticals Business Overview
Table 80. Curium Pharmaceuticals Recent Developments
Table 81. Gilead Sciences Radioimmunotherapy Basic Information
Table 82. Gilead Sciences Radioimmunotherapy Product Overview
Table 83. Gilead Sciences Radioimmunotherapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Gilead Sciences Business Overview
Table 85. Gilead Sciences Recent Developments
Table 86. Clarity Pharmaceuticals Radioimmunotherapy Basic Information
Table 87. Clarity Pharmaceuticals Radioimmunotherapy Product Overview
Table 88. Clarity Pharmaceuticals Radioimmunotherapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Clarity Pharmaceuticals Business Overview
Table 90. Clarity Pharmaceuticals Recent Developments
Table 91. Curasight Radioimmunotherapy Basic Information
Table 92. Curasight Radioimmunotherapy Product Overview
Table 93. Curasight Radioimmunotherapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Curasight Business Overview
Table 95. Curasight Recent Developments
Table 96. Nordic Nanovector Radioimmunotherapy Basic Information
Table 97. Nordic Nanovector Radioimmunotherapy Product Overview
Table 98. Nordic Nanovector Radioimmunotherapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Nordic Nanovector Business Overview
Table 100. Nordic Nanovector Recent Developments
Table 101. Philogen Radioimmunotherapy Basic Information
Table 102. Philogen Radioimmunotherapy Product Overview
Table 103. Philogen Radioimmunotherapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Philogen Business Overview
Table 105. Philogen Recent Developments
Table 106. RadioMedix Radioimmunotherapy Basic Information
Table 107. RadioMedix Radioimmunotherapy Product Overview
Table 108. RadioMedix Radioimmunotherapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. RadioMedix Business Overview
Table 110. RadioMedix Recent Developments
Table 111. Telix Pharmaceuticals Radioimmunotherapy Basic Information
Table 112. Telix Pharmaceuticals Radioimmunotherapy Product Overview
Table 113. Telix Pharmaceuticals Radioimmunotherapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Telix Pharmaceuticals Business Overview
Table 115. Telix Pharmaceuticals Recent Developments
Table 116. Orano Med Radioimmunotherapy Basic Information
Table 117. Orano Med Radioimmunotherapy Product Overview
Table 118. Orano Med Radioimmunotherapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Orano Med Business Overview
Table 120. Orano Med Recent Developments
Table 121. Actinium Pharmaceuticals Radioimmunotherapy Basic Information
Table 122. Actinium Pharmaceuticals Radioimmunotherapy Product Overview
Table 123. Actinium Pharmaceuticals Radioimmunotherapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Actinium Pharmaceuticals Business Overview
Table 125. Actinium Pharmaceuticals Recent Developments
Table 126. Y-mAbs Therapeutics Radioimmunotherapy Basic Information
Table 127. Y-mAbs Therapeutics Radioimmunotherapy Product Overview
Table 128. Y-mAbs Therapeutics Radioimmunotherapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Y-mAbs Therapeutics Business Overview
Table 130. Y-mAbs Therapeutics Recent Developments
Table 131. Fusion Pharmaceuticals Radioimmunotherapy Basic Information
Table 132. Fusion Pharmaceuticals Radioimmunotherapy Product Overview
Table 133. Fusion Pharmaceuticals Radioimmunotherapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. Fusion Pharmaceuticals Business Overview
Table 135. Fusion Pharmaceuticals Recent Developments
Table 136. Global Radioimmunotherapy Sales Forecast by Region (2025-2030) & (Kilotons)
Table 137. Global Radioimmunotherapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 138. North America Radioimmunotherapy Sales Forecast by Country (2025-2030) & (Kilotons)
Table 139. North America Radioimmunotherapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 140. Europe Radioimmunotherapy Sales Forecast by Country (2025-2030) & (Kilotons)
Table 141. Europe Radioimmunotherapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 142. Asia Pacific Radioimmunotherapy Sales Forecast by Region (2025-2030) & (Kilotons)
Table 143. Asia Pacific Radioimmunotherapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 144. South America Radioimmunotherapy Sales Forecast by Country (2025-2030) & (Kilotons)
Table 145. South America Radioimmunotherapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 146. Middle East and Africa Radioimmunotherapy Consumption Forecast by Country (2025-2030) & (Units)
Table 147. Middle East and Africa Radioimmunotherapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 148. Global Radioimmunotherapy Sales Forecast by Type (2025-2030) & (Kilotons)
Table 149. Global Radioimmunotherapy Market Size Forecast by Type (2025-2030) & (M USD)
Table 150. Global Radioimmunotherapy Price Forecast by Type (2025-2030) & (USD/Ton)
Table 151. Global Radioimmunotherapy Sales (Kilotons) Forecast by Application (2025-2030)
Table 152. Global Radioimmunotherapy Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Radioimmunotherapy Market Size Comparison by Region (M USD)
Table 5. Global Radioimmunotherapy Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Radioimmunotherapy Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Radioimmunotherapy Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Radioimmunotherapy Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radioimmunotherapy as of 2022)
Table 10. Global Market Radioimmunotherapy Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Radioimmunotherapy Sales Sites and Area Served
Table 12. Manufacturers Radioimmunotherapy Product Type
Table 13. Global Radioimmunotherapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Radioimmunotherapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Radioimmunotherapy Market Challenges
Table 22. Global Radioimmunotherapy Sales by Type (Kilotons)
Table 23. Global Radioimmunotherapy Market Size by Type (M USD)
Table 24. Global Radioimmunotherapy Sales (Kilotons) by Type (2019-2024)
Table 25. Global Radioimmunotherapy Sales Market Share by Type (2019-2024)
Table 26. Global Radioimmunotherapy Market Size (M USD) by Type (2019-2024)
Table 27. Global Radioimmunotherapy Market Size Share by Type (2019-2024)
Table 28. Global Radioimmunotherapy Price (USD/Ton) by Type (2019-2024)
Table 29. Global Radioimmunotherapy Sales (Kilotons) by Application
Table 30. Global Radioimmunotherapy Market Size by Application
Table 31. Global Radioimmunotherapy Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Radioimmunotherapy Sales Market Share by Application (2019-2024)
Table 33. Global Radioimmunotherapy Sales by Application (2019-2024) & (M USD)
Table 34. Global Radioimmunotherapy Market Share by Application (2019-2024)
Table 35. Global Radioimmunotherapy Sales Growth Rate by Application (2019-2024)
Table 36. Global Radioimmunotherapy Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Radioimmunotherapy Sales Market Share by Region (2019-2024)
Table 38. North America Radioimmunotherapy Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Radioimmunotherapy Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Radioimmunotherapy Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Radioimmunotherapy Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Radioimmunotherapy Sales by Region (2019-2024) & (Kilotons)
Table 43. Bayer Radioimmunotherapy Basic Information
Table 44. Bayer Radioimmunotherapy Product Overview
Table 45. Bayer Radioimmunotherapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Bayer Business Overview
Table 47. Bayer Radioimmunotherapy SWOT Analysis
Table 48. Bayer Recent Developments
Table 49. Novartis Radioimmunotherapy Basic Information
Table 50. Novartis Radioimmunotherapy Product Overview
Table 51. Novartis Radioimmunotherapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Novartis Business Overview
Table 53. Novartis Radioimmunotherapy SWOT Analysis
Table 54. Novartis Recent Developments
Table 55. Lantheus Radioimmunotherapy Basic Information
Table 56. Lantheus Radioimmunotherapy Product Overview
Table 57. Lantheus Radioimmunotherapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Lantheus Radioimmunotherapy SWOT Analysis
Table 59. Lantheus Business Overview
Table 60. Lantheus Recent Developments
Table 61. Aurobindo Pharma Radioimmunotherapy Basic Information
Table 62. Aurobindo Pharma Radioimmunotherapy Product Overview
Table 63. Aurobindo Pharma Radioimmunotherapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Aurobindo Pharma Business Overview
Table 65. Aurobindo Pharma Recent Developments
Table 66. Mundipharma Radioimmunotherapy Basic Information
Table 67. Mundipharma Radioimmunotherapy Product Overview
Table 68. Mundipharma Radioimmunotherapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Mundipharma Business Overview
Table 70. Mundipharma Recent Developments
Table 71. China Isotope and Radiation Radioimmunotherapy Basic Information
Table 72. China Isotope and Radiation Radioimmunotherapy Product Overview
Table 73. China Isotope and Radiation Radioimmunotherapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. China Isotope and Radiation Business Overview
Table 75. China Isotope and Radiation Recent Developments
Table 76. Curium Pharmaceuticals Radioimmunotherapy Basic Information
Table 77. Curium Pharmaceuticals Radioimmunotherapy Product Overview
Table 78. Curium Pharmaceuticals Radioimmunotherapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Curium Pharmaceuticals Business Overview
Table 80. Curium Pharmaceuticals Recent Developments
Table 81. Gilead Sciences Radioimmunotherapy Basic Information
Table 82. Gilead Sciences Radioimmunotherapy Product Overview
Table 83. Gilead Sciences Radioimmunotherapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Gilead Sciences Business Overview
Table 85. Gilead Sciences Recent Developments
Table 86. Clarity Pharmaceuticals Radioimmunotherapy Basic Information
Table 87. Clarity Pharmaceuticals Radioimmunotherapy Product Overview
Table 88. Clarity Pharmaceuticals Radioimmunotherapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Clarity Pharmaceuticals Business Overview
Table 90. Clarity Pharmaceuticals Recent Developments
Table 91. Curasight Radioimmunotherapy Basic Information
Table 92. Curasight Radioimmunotherapy Product Overview
Table 93. Curasight Radioimmunotherapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Curasight Business Overview
Table 95. Curasight Recent Developments
Table 96. Nordic Nanovector Radioimmunotherapy Basic Information
Table 97. Nordic Nanovector Radioimmunotherapy Product Overview
Table 98. Nordic Nanovector Radioimmunotherapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Nordic Nanovector Business Overview
Table 100. Nordic Nanovector Recent Developments
Table 101. Philogen Radioimmunotherapy Basic Information
Table 102. Philogen Radioimmunotherapy Product Overview
Table 103. Philogen Radioimmunotherapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Philogen Business Overview
Table 105. Philogen Recent Developments
Table 106. RadioMedix Radioimmunotherapy Basic Information
Table 107. RadioMedix Radioimmunotherapy Product Overview
Table 108. RadioMedix Radioimmunotherapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. RadioMedix Business Overview
Table 110. RadioMedix Recent Developments
Table 111. Telix Pharmaceuticals Radioimmunotherapy Basic Information
Table 112. Telix Pharmaceuticals Radioimmunotherapy Product Overview
Table 113. Telix Pharmaceuticals Radioimmunotherapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Telix Pharmaceuticals Business Overview
Table 115. Telix Pharmaceuticals Recent Developments
Table 116. Orano Med Radioimmunotherapy Basic Information
Table 117. Orano Med Radioimmunotherapy Product Overview
Table 118. Orano Med Radioimmunotherapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Orano Med Business Overview
Table 120. Orano Med Recent Developments
Table 121. Actinium Pharmaceuticals Radioimmunotherapy Basic Information
Table 122. Actinium Pharmaceuticals Radioimmunotherapy Product Overview
Table 123. Actinium Pharmaceuticals Radioimmunotherapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Actinium Pharmaceuticals Business Overview
Table 125. Actinium Pharmaceuticals Recent Developments
Table 126. Y-mAbs Therapeutics Radioimmunotherapy Basic Information
Table 127. Y-mAbs Therapeutics Radioimmunotherapy Product Overview
Table 128. Y-mAbs Therapeutics Radioimmunotherapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Y-mAbs Therapeutics Business Overview
Table 130. Y-mAbs Therapeutics Recent Developments
Table 131. Fusion Pharmaceuticals Radioimmunotherapy Basic Information
Table 132. Fusion Pharmaceuticals Radioimmunotherapy Product Overview
Table 133. Fusion Pharmaceuticals Radioimmunotherapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. Fusion Pharmaceuticals Business Overview
Table 135. Fusion Pharmaceuticals Recent Developments
Table 136. Global Radioimmunotherapy Sales Forecast by Region (2025-2030) & (Kilotons)
Table 137. Global Radioimmunotherapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 138. North America Radioimmunotherapy Sales Forecast by Country (2025-2030) & (Kilotons)
Table 139. North America Radioimmunotherapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 140. Europe Radioimmunotherapy Sales Forecast by Country (2025-2030) & (Kilotons)
Table 141. Europe Radioimmunotherapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 142. Asia Pacific Radioimmunotherapy Sales Forecast by Region (2025-2030) & (Kilotons)
Table 143. Asia Pacific Radioimmunotherapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 144. South America Radioimmunotherapy Sales Forecast by Country (2025-2030) & (Kilotons)
Table 145. South America Radioimmunotherapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 146. Middle East and Africa Radioimmunotherapy Consumption Forecast by Country (2025-2030) & (Units)
Table 147. Middle East and Africa Radioimmunotherapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 148. Global Radioimmunotherapy Sales Forecast by Type (2025-2030) & (Kilotons)
Table 149. Global Radioimmunotherapy Market Size Forecast by Type (2025-2030) & (M USD)
Table 150. Global Radioimmunotherapy Price Forecast by Type (2025-2030) & (USD/Ton)
Table 151. Global Radioimmunotherapy Sales (Kilotons) Forecast by Application (2025-2030)
Table 152. Global Radioimmunotherapy Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Radioimmunotherapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Radioimmunotherapy Market Size (M USD), 2019-2030
Figure 5. Global Radioimmunotherapy Market Size (M USD) (2019-2030)
Figure 6. Global Radioimmunotherapy Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Radioimmunotherapy Market Size by Country (M USD)
Figure 11. Radioimmunotherapy Sales Share by Manufacturers in 2023
Figure 12. Global Radioimmunotherapy Revenue Share by Manufacturers in 2023
Figure 13. Radioimmunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Radioimmunotherapy Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Radioimmunotherapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Radioimmunotherapy Market Share by Type
Figure 18. Sales Market Share of Radioimmunotherapy by Type (2019-2024)
Figure 19. Sales Market Share of Radioimmunotherapy by Type in 2023
Figure 20. Market Size Share of Radioimmunotherapy by Type (2019-2024)
Figure 21. Market Size Market Share of Radioimmunotherapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Radioimmunotherapy Market Share by Application
Figure 24. Global Radioimmunotherapy Sales Market Share by Application (2019-2024)
Figure 25. Global Radioimmunotherapy Sales Market Share by Application in 2023
Figure 26. Global Radioimmunotherapy Market Share by Application (2019-2024)
Figure 27. Global Radioimmunotherapy Market Share by Application in 2023
Figure 28. Global Radioimmunotherapy Sales Growth Rate by Application (2019-2024)
Figure 29. Global Radioimmunotherapy Sales Market Share by Region (2019-2024)
Figure 30. North America Radioimmunotherapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Radioimmunotherapy Sales Market Share by Country in 2023
Figure 32. U.S. Radioimmunotherapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Radioimmunotherapy Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Radioimmunotherapy Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Radioimmunotherapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Radioimmunotherapy Sales Market Share by Country in 2023
Figure 37. Germany Radioimmunotherapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Radioimmunotherapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Radioimmunotherapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Radioimmunotherapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Radioimmunotherapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Radioimmunotherapy Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Radioimmunotherapy Sales Market Share by Region in 2023
Figure 44. China Radioimmunotherapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Radioimmunotherapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Radioimmunotherapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Radioimmunotherapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Radioimmunotherapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Radioimmunotherapy Sales and Growth Rate (Kilotons)
Figure 50. South America Radioimmunotherapy Sales Market Share by Country in 2023
Figure 51. Brazil Radioimmunotherapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Radioimmunotherapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Radioimmunotherapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Radioimmunotherapy Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Radioimmunotherapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Radioimmunotherapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Radioimmunotherapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Radioimmunotherapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Radioimmunotherapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Radioimmunotherapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Radioimmunotherapy Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Radioimmunotherapy Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Radioimmunotherapy Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Radioimmunotherapy Market Share Forecast by Type (2025-2030)
Figure 65. Global Radioimmunotherapy Sales Forecast by Application (2025-2030)
Figure 66. Global Radioimmunotherapy Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Radioimmunotherapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Radioimmunotherapy Market Size (M USD), 2019-2030
Figure 5. Global Radioimmunotherapy Market Size (M USD) (2019-2030)
Figure 6. Global Radioimmunotherapy Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Radioimmunotherapy Market Size by Country (M USD)
Figure 11. Radioimmunotherapy Sales Share by Manufacturers in 2023
Figure 12. Global Radioimmunotherapy Revenue Share by Manufacturers in 2023
Figure 13. Radioimmunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Radioimmunotherapy Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Radioimmunotherapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Radioimmunotherapy Market Share by Type
Figure 18. Sales Market Share of Radioimmunotherapy by Type (2019-2024)
Figure 19. Sales Market Share of Radioimmunotherapy by Type in 2023
Figure 20. Market Size Share of Radioimmunotherapy by Type (2019-2024)
Figure 21. Market Size Market Share of Radioimmunotherapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Radioimmunotherapy Market Share by Application
Figure 24. Global Radioimmunotherapy Sales Market Share by Application (2019-2024)
Figure 25. Global Radioimmunotherapy Sales Market Share by Application in 2023
Figure 26. Global Radioimmunotherapy Market Share by Application (2019-2024)
Figure 27. Global Radioimmunotherapy Market Share by Application in 2023
Figure 28. Global Radioimmunotherapy Sales Growth Rate by Application (2019-2024)
Figure 29. Global Radioimmunotherapy Sales Market Share by Region (2019-2024)
Figure 30. North America Radioimmunotherapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Radioimmunotherapy Sales Market Share by Country in 2023
Figure 32. U.S. Radioimmunotherapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Radioimmunotherapy Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Radioimmunotherapy Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Radioimmunotherapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Radioimmunotherapy Sales Market Share by Country in 2023
Figure 37. Germany Radioimmunotherapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Radioimmunotherapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Radioimmunotherapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Radioimmunotherapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Radioimmunotherapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Radioimmunotherapy Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Radioimmunotherapy Sales Market Share by Region in 2023
Figure 44. China Radioimmunotherapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Radioimmunotherapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Radioimmunotherapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Radioimmunotherapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Radioimmunotherapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Radioimmunotherapy Sales and Growth Rate (Kilotons)
Figure 50. South America Radioimmunotherapy Sales Market Share by Country in 2023
Figure 51. Brazil Radioimmunotherapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Radioimmunotherapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Radioimmunotherapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Radioimmunotherapy Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Radioimmunotherapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Radioimmunotherapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Radioimmunotherapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Radioimmunotherapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Radioimmunotherapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Radioimmunotherapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Radioimmunotherapy Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Radioimmunotherapy Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Radioimmunotherapy Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Radioimmunotherapy Market Share Forecast by Type (2025-2030)
Figure 65. Global Radioimmunotherapy Sales Forecast by Application (2025-2030)
Figure 66. Global Radioimmunotherapy Market Share Forecast by Application (2025-2030)
